Vanguard Group’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $131M | Buy |
2,564,869
+24,808
| +1% | +$1.26M | ﹤0.01% | 1714 |
|
2025
Q1 | $114M | Buy |
2,540,061
+115,327
| +5% | +$5.2M | ﹤0.01% | 1739 |
|
2024
Q4 | $100M | Sell |
2,424,734
-71,378
| -3% | -$2.95M | ﹤0.01% | 1869 |
|
2024
Q3 | $97.3M | Buy |
2,496,112
+49,379
| +2% | +$1.93M | ﹤0.01% | 1882 |
|
2024
Q2 | $83.7M | Buy |
2,446,733
+235,048
| +11% | +$8.04M | ﹤0.01% | 1920 |
|
2024
Q1 | $55.6M | Sell |
2,211,685
-264,559
| -11% | -$6.65M | ﹤0.01% | 2123 |
|
2023
Q4 | $73.1M | Buy |
2,476,244
+782,901
| +46% | +$23.1M | ﹤0.01% | 2013 |
|
2023
Q3 | $53.5M | Buy |
1,693,343
+98,685
| +6% | +$3.12M | ﹤0.01% | 2101 |
|
2023
Q2 | $41.3M | Buy |
1,594,658
+320,831
| +25% | +$8.3M | ﹤0.01% | 2272 |
|
2023
Q1 | $30.6M | Buy |
1,273,827
+11,529
| +0.9% | +$277K | ﹤0.01% | 2405 |
|
2022
Q4 | $24.6M | Buy |
1,262,298
+17,373
| +1% | +$339K | ﹤0.01% | 2527 |
|
2022
Q3 | $26.2M | Buy |
1,244,925
+261,950
| +27% | +$5.5M | ﹤0.01% | 2516 |
|
2022
Q2 | $19.1M | Buy |
982,975
+217,791
| +28% | +$4.24M | ﹤0.01% | 2657 |
|
2022
Q1 | $16.9M | Sell |
765,184
-43,165
| -5% | -$951K | ﹤0.01% | 2871 |
|
2021
Q4 | $12.9M | Buy |
808,349
+73,702
| +10% | +$1.18M | ﹤0.01% | 3085 |
|
2021
Q3 | $14.6M | Buy |
734,647
+3,150
| +0.4% | +$62.7K | ﹤0.01% | 3033 |
|
2021
Q2 | $12.6M | Sell |
731,497
-9,377
| -1% | -$162K | ﹤0.01% | 3090 |
|
2021
Q1 | $14.7M | Buy |
740,874
+113,078
| +18% | +$2.24M | ﹤0.01% | 2942 |
|
2020
Q4 | $11M | Buy |
627,796
+147,712
| +31% | +$2.58M | ﹤0.01% | 2945 |
|
2020
Q3 | $9.25M | Buy |
480,084
+7,067
| +1% | +$136K | ﹤0.01% | 2827 |
|
2020
Q2 | $9.21M | Buy |
473,017
+299,240
| +172% | +$5.82M | ﹤0.01% | 2813 |
|
2020
Q1 | $2.43M | Buy |
173,777
+93,344
| +116% | +$1.31M | ﹤0.01% | 3248 |
|
2019
Q4 | $1.97M | Sell |
80,433
-1,423
| -2% | -$34.9K | ﹤0.01% | 3459 |
|
2019
Q3 | $823K | Buy |
+81,856
| New | +$823K | ﹤0.01% | 3698 |
|